Report: CV Vaxx Linked to Increased Mortality – 17 Million Deaths
September 30, 2023 | ZeroMandatoryVaxx.com | A scientific report studying 17 Southern-Hemisphere countries found unprecedented increase in mortality after the rollout of the CV vaxx, especially in the elderly population. The data suggest the vaxx did not save lives, but instead resulted in 17 MILLION deaths.
Authors conclude that there was no evidence in a reduction in all-cause mortality (ACM) or any beneficial effect of the CV vaxx.
The researchers stated, “This would correspond to a mass iatrogenic event that killed (0.213 ± 0.006) % of the world population (1 death per 470 living persons, in less than 3 years), and did not measurably prevent any deaths.”
The report is not yet peer-reviewed.
COVID-19 vaccine-associated mortality in the Southern Hemisphere
Link To Full Report HERE
Correlation-Covid-vaccine-mortality-Southern-Hemisphere
By Megan Redshaw
A new scientific report challenges the idea that COVID-19 vaccines have prevented deaths after researchers assessed all-cause mortality in 17 countries and found COVID-19 vaccines did not have any beneficial effect on reducing mortality. Instead, researchers found that unprecedented peaks in high all-cause mortality in each country—especially among the elderly population when COVID-19 vaccines were deployed—coincided with the rollout of third and fourth booster doses.
“This would correspond to a mass iatrogenic event that killed (0.213 ± 0.006) % of the world population (1 death per 470 living persons, in less than 3 years), and did not measurably prevent any deaths,” the authors said. The overall risk of death induced by COVID-19 vaccines is 1,000 times greater than previously reported in data from clinical trials, adverse event monitoring, and cause-of-death statistics obtained from death certificates.
Link To Full Article HERE
Related
Large Study Finds Significant Retinal Eye Damage After CV Vaxx
Sudden deaths surge in athletes after CV injection
PubMed: Engineered graphene oxide (GO) as a vaxx nano-adjuvant
Chinese Patent CN112220919A CV Vaxx contains graphene oxide